![Razan Mohty: Outcomes of patients with IDH1 or 2 mutated AML after alloHCT](https://oncodaily.com/pub/uploads/2024/07/Razan-Mohty-e1722431340748.png)
Photo from Razan Mohty/X
Aug 17, 2024, 07:45
Razan Mohty: Outcomes of patients with IDH1 or 2 mutated AML after alloHCT
Razan Mohty, Assistant Professor at UAB Medicine, shared a post on X about a recent paper published in BMT journal.
Authors: Razan Mohty et al.
“Check our newly published article on outcomes of patients with IDH1 or 2 mutated AML after alloHCT, a study of the ALWP of The EBMT in BMT journal.
Thank you Abdul-Hamid Bazarbachi, Mohamad Mohty, Myriam Labopin, and all co-authors.”
Source: Razan Mohty/X
More posts by Razan Mohty in OncoDaily.